Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects
Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2027-01-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to evaluate the long-term safety and efficacy of ALZ-801 in Early Alzheimer's disease (AD) subjects with the APOE4/4 genotype. This is an open-label trial of treatment with ALZ-801.